Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Gamma-cyclodextrin on the Bioavailability of Berberine
Sponsor: EuroPharma, Inc.
Summary
In this study, we will evaluate the relative bioavailability of Berberine (BB) from capsules containing Indian Barberry (Berberis aristate DC.) Bark and Root Extract in the blood plasma of healthy subjects after oral administration of: A. Capsules containing Berberine and GCD (BBA Berberine MetX™ Ultra Absorption, 250 mg) B. Capsules containing Berberine (BB, Berberine MetX™, 500 mg) - (reference product).
Official title: A Phase I, Randomized, Crossover, Double-blind, Pharmacokinetic Study of Berberine Released From Cyclodextrin in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2024-09
Completion Date
2026-12
Last Updated
2023-09-14
Healthy Volunteers
Yes
Conditions
Interventions
Berberine incorporated in gamma cyclodextrin
Experimental modified product. One capsule contains 250 mg of Berberine from Indian Barberry (Berberis aristate DC.) Bark and Root Extract incorporated in gamma-cyclodextrin
Berberine
Active comparator. One capsule contains 500 mg of Berberine from Indian Barberry (Berberis aristate DC.) Bark and Root Extract
Locations (4)
CARDIOMED Family Health Center, LLC of the Ministry of Health of the Republic of Armenia
Yerevan, Armenia
Institute of Fine Organic Chemistry of the National Academy of Science
Yerevan, Armenia
Scientific Center of Drug and Medical Technologies Expertise
Yerevan, Armenia
Phytomed AB
Våxtorp, HL, Sweden